Effect of intra-amniotic oestriol sulphate on uterine contractions.
Journal: 1969/July - British Medical Journal
ISSN: 0007-1447
PUBMED: 5784612
Abstract:
The effects of oestriol sulphate on myometrial activity in a group of young primigravidae, who were at 41 or more weeks' gestation, are compared with those of a placebo in a double-blind trial. Both compounds were administered over a period of six hours directly into the uterine cavity following artificial rupture of membranes. Intra-amniotic pressure recordings demonstrated a peak in the mean intensity in uterine contractions in the oestriol-treated and placebo-treated groups at six and four hours, respectively. The length of labour tended to be shorter in those patients having greater uterine activity.
Relations:
Content
Citations
(2)
References
(4)
Drugs
(1)
Chemicals
(1)
Organisms
(1)
Processes
(4)
Anatomy
(3)
Similar articles
Articles by the same authors
Discussion board
Br Med J 2(5660): 786-789

Effect of Intra-amniotic Oestriol Sulphate on Uterine Contractions

Abstract

The effects of oestriol sulphate on myometrial activity in a group of young primigravidae, who were at 41 or more weeks' gestation, are compared with those of a placebo in a double-blind trial. Both compounds were administered over a period of six hours directly into the uterine cavity following artificial rupture of membranes. Intra-amniotic pressure recordings demonstrated a peak in the mean intensity in uterine contractions in the oestriol-treated and placebo-treated groups at six and four hours, respectively. The length of labour tended to be shorter in those patients having greater uterine activity.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (876K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • DICZFALUSY E, CASSMER O, ALONSO C, DE MIQUEL M. Estrogen metabolism in the human fetus and newborn. Recent Prog Horm Res. 1961;17:147–206. [PubMed] [Google Scholar]
  • Goebelsmann U, Wiqvist N, Diczfalusy E, Levitz M, Condon GP, Dancis J. Fate of intra-amniotically administered oestriol-15-3H-3-sulphate and oestriol-16-14C-16-glucosiduronate in pregnant women at midterm. Acta Endocrinol (Copenh) 1966 Aug;52(4):550–564. [PubMed] [Google Scholar]
  • KLOPPER A, BILLEWICZ W. URINARY EXCRETION OF OESTRIOL AND PREGNANEDIOL DURING NORMAL PREGNANCY. J Obstet Gynaecol Br Commonw. 1963 Dec;70:1024–1033. [PubMed] [Google Scholar]
  • Pinto RM, Leon C, Mazzocco N, Scasserra V. Action of estradiol-17-beta at term and at onset of labor. Am J Obstet Gynecol. 1967 Jun 15;98(4):540–546. [PubMed] [Google Scholar]
Abstract
The effects of oestriol sulphate on myometrial activity in a group of young primigravidae, who were at 41 or more weeks' gestation, are compared with those of a placebo in a double-blind trial. Both compounds were administered over a period of six hours directly into the uterine cavity following artificial rupture of membranes. Intra-amniotic pressure recordings demonstrated a peak in the mean intensity in uterine contractions in the oestriol-treated and placebo-treated groups at six and four hours, respectively. The length of labour tended to be shorter in those patients having greater uterine activity.
Collaboration tool especially designed for Life Science professionals.Drag-and-drop any entity to your messages.